CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma
暂无分享，去创建一个
Kenji Suzuki | M. Itoh | H. Kawaji | Y. Mitsuishi | F. Takahashi | K. Takamochi | T. Shukuya | K. Tajima | Wira Winardi | Kazuhisa Takahashi | K. Hara | Y. Suehara | R. Ko | T. Asao | Kentaro Suina | K. Kanamori | Tsuyoshi Saito | T. Mimori | T. Hayashi | S. Shimamura | Ken Tajima